Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
20 January 2023 - 12:28AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR
15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2023
Commission File Number: 001-37384
GALAPAGOS NV
(Translation of registrants name into English)
Generaal De
Wittelaan L11 A3
2800 Mechelen, Belgium
(Address of principal executive office)
Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Note: Regulation S-T Rule 101(b)(1) only permits the
submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Note: Regulation S-T Rule 101(b)(7) only permits the
submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the
registrant is incorporated, domiciled or legally organized (the registrants home country), or under the rules of the home country exchange on which the registrants securities are traded, as long as the report or other
document is not a press release, is not required to be and has not been distributed to the registrants security holders, and, if discussing a material event, has already been the subject of a Form 6-K
submission or other Commission filing on EDGAR.
Corporate Presentation
On January 9, 2023, Paul Stoffels (acting via Stoffels IMC BV), Chief Executive Officer of the Registrant, presented at the 41st annual J.P. Morgan Healthcare Conference in San Francisco, which took place from January 9-12, 2023. The Registrant prepared the corporate presentation for
use during meetings throughout the J.P. Morgan Healthcare Conference. A copy of the corporate presentation is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
|
|
|
Exhibit |
|
Description |
|
|
99.1 |
|
Corporate Presentation, titled J.P. Morgan Healthcare Conference, dated January 9, 2023
The information contained in slides numbered 6, 8, 9 and 18 featured in
Exhibit 99.1 of this Report on Form 6-K, is hereby incorporated by reference into the Companys Registration Statements on Form S-8
(File Nos. 333-204567, 333-208697, 333-211834, 333-215783,
333-218160, 333-225263, 333-231765, 333-249416,
333-260500 and 333-268756). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
GALAPAGOS NV |
|
|
|
|
|
|
|
|
|
|
(Registrant) |
|
|
|
|
Date: January 19, 2023 |
|
|
|
|
|
/s/ Annelies Denecker |
|
|
|
|
|
|
Annelies Denecker |
|
|
|
|
|
|
Company Secretary |
Galapagos NV (PK) (USOTC:GLPGF)
Historical Stock Chart
From May 2024 to Jun 2024
Galapagos NV (PK) (USOTC:GLPGF)
Historical Stock Chart
From Jun 2023 to Jun 2024